type here...

CATEGORIES

Pharmaceutics

LATEST

1...789...11Page 8 of 11

TRENDING

EDITORS CHOICE

Uqora Develops the First Non-Antibiotic Treatment Option for UTIs

Medika Life -
The new drug program aims to decrease the amount of UTIs that would otherwise require antibiotic intervention.

BIO – Biotech Without Borders 

Gil Bashe, Medika Life Editor -
This year’s gathering in Boston—a city long synonymous with health innovation—welcomed more than 20,000 attendees from across the globe. But what stood out most...

INOVIO Receives $71 Million Contract From U.S. Department of Defense

Medika Life -
CELLECTRA® 3PSP is designed to deliver INO-4800 directly into the skin, where the vaccine prompts the body's immune system to drive a robust immune response

Abatacept

Medika Life -
ORENCIA® (abatacept) is a selective T cell costimulation modulator. ORENCIA is a soluble fusion protein that consists of the extracellular domain

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories